Why Quality Shareback is the Missing Fuel for the Healthcare Interoperability Engine
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is…
Why Quality Shareback is the Missing Fuel for the Healthcare Interoperability Engine
The question is no longer whether shareback matters. It is whether the healthcare ecosystem is willing to prioritize it in practice by recognizing it in policy measurement, monitoring, and enforcement, as well as investing in the technical and governance structures needed to make shareback routine, high-quality, measurable, and reportable. The post Why Quality Shareback is…
The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet
Healthcare has solved for the hard part. The science, the surgery, the diagnosis: by global standards, we’re exceptional. What we haven’t solved for is what happens when the patient goes home. The post The Healthcare Industry Has a Last Mile Problem — It Hasn’t Realized It Yet appeared first on MedCity News.
Companies Expand AI Health Offerings, Even as Accuracy Questions Remain — The Monitor
Five technology companies have launched dedicated consumer-facing AI health tools so far in 2026, reflecting though questions about AI’s reliability remain. And a decades-old WHO classification has been misrepresented online to suggest that hormonal birth control pills were recently found to cause cancer.
How are payers and providers using AI? And why isn’t AI reducing administrative cost?
The Peterson Health Technology Institute (PHTI) recently released a report titled: “Administrative AI: Current Use and Potential Impact.” The report was based on a workshop PHTI convened with senior leaders from health systems, health plans, technology developers, investment firms, and federal agencies in order to discuss how technology and policy can enable AI to reduce…
How the DOJ Is Tackling Fraud in the ACA Marketplace
At the Medicarians Conference, Ricardo Carcas, assistant special agent in charge of the Office of Investigations, discussed cases of fraud in the ACA and how the DOJ is combatting it. The post How the DOJ Is Tackling Fraud in the ACA Marketplace appeared first on MedCity News.
FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of action to suppressing HIV. The post FDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral…
Legislative Efforts to Curb Prescription Drug Prices Gain Momentum Across the U.S.
Virginia’s General Assembly is set to vote on the Affordable Medicine Act, aiming to extend Medicare drug price negotiations to state plans
AcademyHealth: AHRQ Is ‘Funded But Frozen’
Organization’s CEO Aaron Carroll says that despite congressional funding, Agency for Healthcare Research and Quality is not issuing new grants
Wearable Noise Is Exploding — Trust Is the Filter
The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning. The post Wearable Noise Is Exploding — Trust Is the Filter appeared first on MedCity News.
Trust, Technology and the Future of Interoperability: Solving Problems That Impact Real Lives
Healthcare interoperability isn’t an abstract concept; it’s about human connection, building trust and easing burden on patients and their care providers. The post Trust, Technology and the Future of Interoperability: Solving Problems That Impact Real Lives appeared first on MedCity News.
